Stryker Stock May Gain From Oculan Lighting Platform's Launch

Zacks11-20 22:29

Stryker Corporation SYK unveiled the Oculan Lighting Platform, an innovative lighting solution designed to provide consistent, high-quality illumination, allowing surgeons to focus on delivering the ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2485149491?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/OqpBwYnlazUrZRs4ONCSFw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958","is_english":true,"pubTime":"2024-11-20 22:29","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2485149491","market":"us","top_or_hot":-1,"title":"Stryker Stock May Gain From Oculan Lighting Platform's Launch","media":"Zacks","content":"<div>\n<p>Stryker Corporation SYK unveiled the Oculan Lighting Platform, an innovative lighting solution designed to provide consistent, high-quality illumination, allowing surgeons to focus on delivering the ...</p>\n\n<a href=\"https://finance.yahoo.com/news/stryker-stock-may-gain-oculan-142900501.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stryker Stock May Gain From Oculan Lighting Platform's Launch</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStryker Stock May Gain From Oculan Lighting Platform's Launch\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-20 22:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/stryker-stock-may-gain-oculan-142900501.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stryker Corporation SYK unveiled the Oculan Lighting Platform, an innovative lighting solution designed to provide consistent, high-quality illumination, allowing surgeons to focus on delivering the ...</p>\n\n<a href=\"https://finance.yahoo.com/news/stryker-stock-may-gain-oculan-142900501.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://finance.yahoo.com/news/stryker-stock-may-gain-oculan-142900501.html","article_id":"2485149491","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/OqpBwYnlazUrZRs4ONCSFw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2485149491","pubTimestamp":1732112940,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Stryker Corporation SYK unveiled the Oculan Lighting Platform, an innovative lighting solution designed to provide consistent, high-quality illumination, allowing surgeons to focus on delivering the highest standard of care.The Oculan Lighting Platform excels in providing bright, even light in hard-to-reach spaces, wherein surgeons need it most. The platform’s enhanced contrast capabilities allow surgeons to distinguish between different tissues and anatomical structures more easily.Given the market potential for surgical lighting, SYK’s Oculan Lighting Platform is likely to provide a boost to the company’s business and generate additional revenues. This can further help the stock’s price to rise.The Auto Lux and Microspot features provide uniform brightness and pure white even in harder-to-reach areas such as a deep cavity or small incision procedures. The SHD Mode of the platform allows for the removal of perceived red to improve contrast, tissue differentiation and reduction of glar","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","LU0882574055.USD":"富达全球健康医疗A ACC","LU2404859741.USD":"FUNDSMITH EQUITY FUND \"R\" (USD) INC","BK4588":"碎股","LU2404859667.USD":"FUNDSMITH EQUITY FUND \"R\" (USD) ACC","LU0690374961.EUR":"FUNDSMITH EQUITY \"R\" (EUR) INC","LU0690374615.EUR":"FUNDSMITH EQUITY \"R\" (EUR) ACC","ANGO":"阿吉奥动态","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC","BK4566":"资本集团","BK4504":"桥水持仓","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","LU0205193047.USD":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD)  ACC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU0528227936.USD":"富达环球人口趋势基金A-ACC","LU0240877869.USD":"SCHRODER ISF GLOBAL SMALL COMPANIES \"A\" ACC","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","MASI":"麦斯莫医疗","LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","BK4017":"黄金","LU2065732104.USD":"ALLSPRING (LUX) WF GLOBAL SMALL CAP EQUITY \"I\" (USD) ACC","LU1791710400.SGD":"Fidelity Global Demographics A-ACC-SGD","LU0205194284.USD":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD) INC AV","GB00B4QBRK32.GBP":"FUNDSMITH EQUITY \"R\" (GBP) INC","GMED":"Globus Medical Inc","GB00B4LPDJ14.GBP":"FUNDSMITH EQUITY \"R\" (GBP) ACC","SYK":"史赛克","BK4585":"ETF&股票定投概念","LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","IE0009354923.USD":"JANUS HENDERSON US VENTURE \"A2\" (USD) ACC","LU0240878834.USD":"SCHRODER ISF GLOBAL SMALL COMPANIES \"A\" (USD) INC AV","OR":"Osisko Gold Royalties Ltd"},"translate_title":"Stryker股票可能会从Oculan照明平台的推出中受益","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SYK":1,"OR":1,"MASI":1,"ANGO":1,"GMED":0.9},"content_text":"Stryker Corporation SYK unveiled the Oculan Lighting Platform, an innovative lighting solution designed to provide consistent, high-quality illumination, allowing surgeons to focus on delivering the highest standard of care.\nThe Oculan Lighting Platform excels in providing bright, even light in hard-to-reach spaces, wherein surgeons need it most. The platform’s enhanced contrast capabilities allow surgeons to distinguish between different tissues and anatomical structures more easily.\nLikely Trend of SYK Stock Following the News\nFollowing the announcement, shares of the company closed flat at $388.68 at yesterday’s closing. In the year-to-date period, SYK shares have gained 29.8% compared with the industry’s 14.2% growth. The S&P 500 increased 24% in the same time frame.\nGiven the market potential for surgical lighting, SYK’s Oculan Lighting Platform is likely to provide a boost to the company’s business and generate additional revenues. This can further help the stock’s price to rise.\nSYK currently has a market capitalization of $148.5 million. In the last reported quarter, SYK delivered an earnings surprise of 3.2%.\nImage Source: Zacks Investment Research\n \nMore on the SYK’s Oculan Lighting Platform\nIn today's operating rooms (OR), when accuracy and precision are crucial, even the smallest difficulties can affect surgical results and make it more difficult for a surgeon to see properly and perform their job effectively. Clear visualization is one of the most critical aspects of surgical lighting. The Oculan Lighting Platform is designed to improve the visualization experience, surgical performance and patient safety within the operating room.\nThe Oculan Lighting Platform is made with long-term performance in consideration, with an emphasis on durability. Surgical teams can quickly modify settings to suit their own requirements thanks to its user-friendly interface. Suspension modularity allows for the Oculan Lighting Platform to be installed in operating rooms with existing Stryker surgical lights, causing minimal OR downtime.\nThe platform offers advanced features designed to enhance surgical precision and comfort. Its Fly Eye technology within the optical architecture ensures that instruments, hands and the surgeon's head do not create dim areas, providing even light distribution. The Oculan Platform provides consistent illumination, which allows surgeons to maintain a clear view and is designed to increase optical efficiency and reduce color ringing at the surgical site within procedures.\nThe Auto Lux and Microspot features provide uniform brightness and pure white even in harder-to-reach areas such as a deep cavity or small incision procedures. The SHD Mode of the platform allows for the removal of perceived red to improve contrast, tissue differentiation and reduction of glare off instrumentation to improve the visual experience. The platform is designed to produce less heat through heat dissipation, creating a cooler, more comfortable environment for lengthy surgeries. Reduced glare and reflection help surgeons stay focused and minimize eye strain.\nFavorable Industry Prospects for SYK\nPer a report by Grand View Research, the global surgical lights market size was valued at $1.85 billion in 2023 and is projected to grow at a CAGR of 5.9% from 2024 to 2030.\nA rise in regulatory approvals for operating room equipment, coupled with a rising focus on offering better patient care across different healthcare facilities, is expected to drive the demand for surgical lights. Factors, such as rising product availability, high demand for well-equipped operating rooms by healthcare professionals and surgeons, and accessibility of healthcare facilities, especially in emerging economies, are projected to further propel the growth of the market for surgical lights.\nSYK’s Zacks Rank & Stocks to Consider\nSYK carries a Zacks Rank #3 (Hold) at present.\nSome better-ranked stocks from the medical industry are Masimo MASI, AngioDynamics ANGO and Globus Medical GMED.\nMasimo, sporting a Zacks Rank #1 (Strong Buy) at present, has an estimated growth rate of 10.4% for 2025. You can see the complete list of today’s Zacks #1 Rank stocks here.\nMASI’s earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 17.10%. Masimo’s shares have risen 37.2% year to date compared with the industry’s 6.7% growth.\nAngioDynamics, currently carrying a Zacks Rank #2 (Buy), has an estimated growth rate of 38.2% for 2025. ANGO’s earnings surpassed estimates in three of the trailing four quarters and missed once, delivering an average surprise of 31.71%.\nAngioDynamics’ shares have lost 8.9% year to date against the industry’s 6.7% growth.\nGlobus Medical, carrying a Zacks Rank of 2 at present, has an estimated long-term growth rate of 12.7%. GMED’s earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 12.1%. Its shares have risen 56.5% year to date compared with the industry’s 6.7% growth.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nAngioDynamics, Inc. (ANGO) : Free Stock Analysis Report\nStryker Corporation (SYK) : Free Stock Analysis Report\nMasimo Corporation (MASI) : Free Stock Analysis Report\nGlobus Medical, Inc. (GMED) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"Product Release","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2485149491"}